NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation

  1. Chuan-Jin Wu and
  2. Jonathan D. Ashwell*
  1. Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
  1. Communicated by Arthur Weiss, University of California, San Francisco, CA, January 2, 2008 (received for review September 19, 2007)

Abstract

The mechanism by which the Carma1–Bcl10–MALT1 (CBM) complex couples T cell antigen receptor (TCR) signaling to IκB kinase (IKK) and NF-κB activation is not known. Here, we show that Bcl10 undergoes K63-linked polyubiquitination in response to T cell activation and subsequently binds NEMO, the regulatory subunit of IKK. This interaction requires the ubiquitin-binding activity of NEMO. The sites of Bcl10 ubiquitination were mapped to K31 and K63. Mutation of these residues did not affect TCR signaling-induced CBM complex assembly but prevented Bcl10 ubiquitination, NEMO binding, and NF-κB activation. Therefore, the regulated ubiquitination of Bcl10 and its recognition by NEMO are a critical link between the CBM complex, IKK recruitment, and NF-κB activation.

Footnotes

  • *To whom correspondence should be addressed. E-mail: jda{at}pop.nci.nih.gov
  • Author contributions: C.-J.W. and J.D.A. designed research; C.-J.W. performed research; C.-J.W. and J.D.A. analyzed data; and C.-J.W. and J.D.A. wrote the paper.

  • The authors declare no conflict of interest.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0712313105/DC1.

« Previous | Next Article »Table of Contents